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SUMMARY
Interval-censored longitudinal data taken from a Norwegian study of individuals with Parkinson’s disease
are investigated with respect to the onset of dementia. Of interest are risk factors for dementia and the
subdivision of total life expectancy (LE) into LE with and without dementia. To estimate LEs using ex-
trapolation, a parametric continuous-time 3-state illness–death Markov model is presented in a Bayesian
framework. The framework is well suited to allow for heterogeneity via random effects and to investi-
gate additional computation using model parameters. In the estimation of LEs, microsimulation is used
to take into account random effects. Intensities of moving between the states are allowed to change in a
piecewise-constant fashion by linking them to age as a time-dependent covariate. Possible right censoring
at the end of the follow-up can be incorporated. The model is applicable in many situations where indi-
viduals are followed over a long time period. In describing how a disease develops over time, the model
can help to predict future need for health care.
Keywords: Dementia; Life expectancy; Microsimulation; Multistate model; Random effects; Right censoring;
Survival.
1. INTRODUCTION
Many population studies now have longitudinal follow-up and mortality information that can be combined
to investigate transitions between health and ill health prior to death. Multistate models can be used to de-
scribe these transitions when states reﬂect health status and a death state is included. In describing how a
disease develops over time, the models can help to predict future need for health care. Examples of appli-
cations are studies where patients are followed after a surgical operation, studies where stages of a disease
are monitored after an infection, and longitudinal epidemiological studies. Our research was initiated by a
Norwegian study into dementia and survival among patients with Parkinson’s disease (Buter and others,
2008). In this study, the health states are “no dementia, dementia, and death,” with the assumption that
transitions from dementia to no dementia are not possible. Individuals with Parkinson’s disease are more
likely to develop dementia than individuals without the disease (see, e.g. de Lau and others, 2005). For
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individuals with Parkinson’s disease, the onset of dementia is an important predictor of health and need
for care.
ThispaperpresentsBayesianinferenceforacontinuous-time3-stateillness–deathMarkovmodel.The
intensities of moving between the states are related to covariates and random effects. By including age
as a time-dependent covariate, time dependency of intensities can be taken into account in a piecewise-
constant fashion. Relaxing the assumption of constant intensities makes the model applicable in many
situations where individuals are followed over a long time period. One way to make use of the random-
effect structure is to model possible heterogeneity that is not captured by observed covariates. The model
in this paper assumes that transition times are interval censored except for known death times. Right
censoring at the end of follow-up can be incorporated.
In addition, we show how to apply the Markov model to estimate life expectancy (LE). Using a para-
metric model for the time-dependent intensities makes it possible to extrapolate the model beyond the
follow-up time and to estimate how many years of total LE will be spent in a disease state and which
risk factors are important. In the presence of a random-effect structure, microsimulation can be used to
estimate LE.
For the Norwegian study, Buter and others (2008) ﬁtted a 3-state ﬁxed-effect model using maximum
likelihood estimation. They presented LEs conditional on baseline state and used a nonparametric boot-
strap to estimate the variance of the estimated LEs. The Bayesian approach makes it easy to incorporate
random effects, and there is no need for an additional stage for the estimation of the distribution of LEs
because the approach is well suited to investigate derived variables from posterior distributions of the
model parameters. In addition to the LEs conditional on baseline state, we estimate marginal LEs that do
not require a speciﬁed baseline state but instead require the distribution of the baseline state.
One of the ﬁrst publications on Bayesian inference for continuous-time multistate models is Sharples
(1993). In recent years, additional work has been presented by, for example, Welton and Ades (2005) and
Pan and others (2007). Our work can be seen as an extension to the Bayesian inference in Pan and others
(2007) in that we allow for time-dependent intensities and exact death times.
Laditka and Wolf (1998) used microsimulation to estimate active LE given a ﬁxed-effect discrete-
time Markov model. The variance of estimated LE, however, was not discussed. To estimate the variance
of quantities that are derived by using microsimulation, ﬁrst- and second-order uncertainty have to be
distinguished (Halpern and others, 2000). We will show how this is handled in our setting.
An important aspect of the data that determine the model chosen is whether or not transition times
are known. For Bayesian inference given a multistate model with known transition times, see Kneib and
Hennerfeind (2008). In our setting, as is common in many studies, known transition times are not available
except for the transition into the death state. The disease status of the individuals is observed at presched-
uled interviews, and as a consequence, observations are interval censored. Our multistate model is deﬁned
using transition intensities, but the likelihood contributions of observed time intervals are deﬁned using
transitionprobabilities.Inthisway,weaccountfortheintervalcensoringinlinewithfrequentistmultistate
models (see, e.g. Kay, 1986).
The paper is organized as follows. Section 2 introduces the model, and Section 3 shows how to esti-
mate LEs given the model with random effects. In Section 4, an extension of the model is presented to
take right censoring into account. Section 5 discusses the application, and Section 6 concludes the paper.
2. MARKOV MODEL
The ﬁrst-order Markov assumption in a multistate model implies that the probability of moving to another
state only depends on the current state. Our 3-state Markov model assumes that there is no recovery from
State 2 back to State 1 and that known transition times are only available for transitions into the death state.
We regress intensities on age as a time-dependent covariate to model possible change in the intensities.Estimating dementia-free life expectancy 731
In the model, the time interval between 2 consecutive measurements is not ﬁxed but is allowed to
vary between and within individuals. Although the model is formulated for individually observed time
intervals, the subscript denoting individuals will be suppressed in order to keep notation simple. Let
t denote time since entry to the study. At time t  0, the state of an individual is xt ∈{ 1,2,3}.A
transition at time t from State r to State s, r  = s, occurs with intensity qrs(t), where qrs(t)  0 for
(r,s) ∈{ (1,2),(1,3),(2,3)} and qrs(t) = 0 for (r,s) ∈{ (2,1),(3,1),(3,2)}. Intensities are regressed
on covariates and random effects by the log-linear model
qrs(t) = exp[β β β 
rsz z z(t) + τrs], (2.1)
wherev  denotesthetransposeofvectorv,β β βrs = (β0.rs,β 1.rs,...,βp.rs) , z z z(t) = (1,z1(t),...,zp(t)) ,
and random-effect parameter τ τ τ = (τ12,τ 13,τ 23)  is multivariate normally distributed with mean zero and
unknown covariance matrix      . The model is ﬂexible to other random-effect structures as will be illus-
trated in the application.
The time dependency of the intensities is taken into account by a piecewise-constant approximation:
intensities are assumed to be constant within individually observed time intervals but may vary between
intervals. In our model, covariate vector z z z(t) is deterministic in the sense that we know its values at every
time t  0. A typical example of this is the time-dependent covariate age. The constant intensities qrs(t)
for an observed interval (t,u] are deﬁned using the covariate values midway, that is, at time (t + u)/2.
In case observed time intervals are wide and/or the time dependency is strong, this approach can be ﬁne-
tuned by subdividing observed intervals in shorter intervals and assuming that intensities are constant
within the shorter intervals (Van den Hout and Matthews, 2008), but this method is not required here.
The statistical model is deﬁned using transition probabilities, that is, probabilities of moving between
the states. Transition probabilities for an observed time interval (t,u] are given by the 3 × 3 matrix
P P P(t,u) = exp[(u − t)Q Q Q(t)], where for t  0 we deﬁne
Q Q Q(t) =
⎛
⎜
⎝
−[q12(t) + q13(t)] q12(t) q13(t)
0 −q23(t) q23(t)
00 0
⎞
⎟
⎠ (2.2)
and where exp[M M M] is deﬁned for any square matrix M M M as the limit of the series
 ∞
k=0 M M Mk/k!. The rs-
entry P P P(t,u)[r,s]i sg i v e nb yP(Xu = s|Xt = r). See, for example, Norris (1997) for details on time-
continuous Markov chains with constant intensities. Matrix P P P(t,u) is available in closed form for the
3-state model without recovery.
Assume that an individual has observations at times t1 = 0, t2,...,tM. Using the Markov assumption,
the probability of the observed trajectory xt1,xt2,...,xtM conditional on the ﬁrst observation xt1 is given
by
P
 
Xt2 = xt2|Xt1 = xt1
 
×···×P
 
XtM = xtM|XtM−1 = xtM−1
 
, (2.3)
where the conditioning on covariates and random effects is ignored in the notation. The contribution of
this individual to the marginal likelihood is given by
 
R3
P
 
Xt2 = xt2|Xt1 = xt1
 
×···×P
 
XtM = xtM|XtM−1 = xtM−1
 
f (τ τ τ)dτ τ τ, (2.4)
where f is the density of the multivariate normal distribution with mean zero and covariance matrix      .
To obtain the likelihood for the data, the individual contributions are taken together in a multiplication.
Given that the goal is Bayesian inference, we will use Markov chain Monte Carlo (MCMC) methods
for approximating posterior distributions of model parameters. To do this, observed intervals (t1,t2],...,732 A. VAN DEN HOUT AND F. E. MATTHEWS
(tM−1,tM] are modeled independently by using the multinomial distribution for the transitions to State
X j+1 given State X j, j = 1,...,M − 1( P a nand others, 2007).
Assume that the individual with observation times t1 = 0,t2,...,tM has random-effect parameter
vector τ τ τ. We recode States 1, 2, and 3 as (1,0,0), (0,1,0), and (0,0,1), respectively. Accordingly, we
change the notation for the random variable that denotes the state from scalar X to vector X X X. For intervals
(tj,tj+1] that an individual survives, we assume that
X X X j+1| xtj,β β β12,β β β13,β β β23,τ τ τ ∼ Multinomial(π π π j+1,1),
τ τ τ|       ∼ MVN(0 0 0,     ),
where
π π π j+1 =
 
P P P(tj,tj+1)
 
xtj,1
 
, P P P(tj,tj+1)
 
xtj,2
 
, P P P(tj,tj+1)
 
xtj,3
  
, (2.5)
for j ∈{ 1,...,M − 1}.
In case an individual does not survive (tM−1,tM], we assume that
X X XtM| xtM−1,β β β12,β β β13,β β β23,τ τ τ ∼ Multinomial(π π πM,1),
where
π π πM =
 
P P P(tM−1,tM)
 
xtM−1,1
 
(1 − πd)
1 − P P P(tM−1,tM)
 
xtM−1,3
  ,
P P P(tM−1,tM)
 
xtM−1,2
 
(1 − πd)
1 − P P P(tM−1,tM)
 
xtM−1,3
  ,π d
 
(2.6)
given
πd = P P P(tM−1,tM −  )
 
xtM−1,1
 
×P P P(tM −  ,tM)[1,3]
+P P P(tM−1,tM −  )
 
xtM−1,2
 
×P P P(tM −  ,tM)[2,3]. (2.7)
This means that in case of death at tM, we assume an unknown state just before death and then a tran-
sition into the death state within a small time interval   (cf. Sharples, 1993). The probability of this
event is denoted by πd. Because of the  -approximation of the exact death time in (2.7), 1 − πd  =
P P P(tM−1,tM)
 
xtM−1,1
 
+ P P P(tM−1,tM)
 
xtM−1,2
 
, hence the adjustment in (2.6) to ensure a proper dis-
tribution. Even though exact death times are known, we adhere to the  -approximation. In maximum
likelihood estimation, instantaneous intensities can be used, and in that case, the likelihood contribution
of an observed death time would be P P P(tM−1,tM)
 
xtM−1,1
 
q13(t)+P P P(tM−1,tM)
 
xtM−1,2
 
q23(t) (see, e.g.
Van den Hout and Matthews, 2009). In the Bayesian framework, we have to ensure that πd is a probability,
that is, 0  πd  1, and we use the  -approximation.
To estimate the total LE, the distribution of the state at baseline t1 = 0 is needed. At baseline, the state
iseitherState1orState2.Weproposetousethelogisticregressionmodelforthedistributionof X0 = Xt1.
Deﬁning θ = P(X0 = 2|z z z(0)), this model is given by logit(θ) = α α α z z z(0), where α α α = (α1,...,αp) .I t
follows that
X X X0 ∼ Bernoulli(θ).
Foreaseofexposition,weusethesamecovariatevectorforthebaselinedistributionandfortheintensities.
This is not a necessary condition.
The following priors are used for the model parameters in the application. For the regression coef-
ﬁcients in the model for baseline state and the regression coefﬁcients in the Markov model, we specify
vague univariate normal distributions with mean zero and large variance. For the inverse of covariance
matrix      , we specify a Wishart distribution. These choices will be illustrated in Section 5.Estimating dementia-free life expectancy 733
With both the distribution of the data and the prior distribution of the parameters speciﬁed, MCMC
methods can be used to estimate the model. The models in this paper were programmed and run in Open-
BUGS (Thomas and others, 2006). Output of OpenBUGS can be transported into R (R Development Core
Team, 2008) using the R package coda (Plummer and others, 2006).
3. LES AND MICROSIMULATION
For the case without random effects, LE in State s ∈{ 1,2} given initial state r ∈{ 1,2} is given by
ers(Z) = E
   ∞
0
1 l{In State s at t}dt
 
 r,Z
 
=
  ∞
0
P(Xt = s| X0 = r,Z)dt, (3.1)
where Z ={ z z z(t)|t  0}. Expected LE in State s irrespective of the initial state (marginal LE) is given by
es(Z) =
2  
r=1
P(X0 = r|Z)ers(Z) = (1 − θ)e1s(Z) + θe2s(Z), (3.2)
where θ = P(X0 = 2|Z) is as deﬁned in Section 2. Expected total LE is given by etot(Z) = e1(Z) +
e2(Z). For applications of LEs given frequentists illness–death Markov models, see, for example,
Izmirlian and others (2000) and Li` evre and others (2003).
Two methods can be used to estimate the posterior distribution of LEs. The ﬁrst approximates the
integral in (3.1) numerically, for example, by using the trapezoidal rule. The second is microsimulation
where individual trajectories are simulated and corresponding individual survival is used to estimate LEs.
Both methods can be applied within each MCMC run or after convergence using the posterior distribution
of the model parameters. Straightforward numerical evaluation is possible if the covariate vector z z z(t) is
deterministic in the sense that conditional on z z z(0), Z is completely speciﬁed. Microsimulation is more
ﬂexibleinthatitcanalsodealwithrandomeffectsandwithtime-dependentcovariatessuchasinformation
about visited states. Microsimulation has been used in evaluating screening interventions (Cronin and
others, 1998) and in cost-effectiveness modeling (Spiegelhalter and Best, 2003).
3.1 Using the trapezoidal rule
For each simulated parameter vector of the Markov model, the trapezoidal rule is applied to estimate
ers(Z). Using the simulated parameter vectors of the baseline distribution, we derive the posteriors of
marginal LEs and total LE.
It make sense to use one time grid for both the trapezoidal rule and the piecewise-constant model.
Given time grid u1 = 0,u2,...,uM, we approximate integrand P
 
Xu j = s| X0 = r,Z
 
for all j ∈
{2,...,M}. To take into account the time dependency of the intensities, we use a piecewise-constant
iterative method given by
  P P P(0,u j) = P P P(0,u2)P P P(u2,u3) ×···×P P P(u j−1,u j). (3.3)
We use   P P P(0,u j) as an approximation for P P P(0,u j). Whereas in the estimation of the model we use in-
dividually observed time intervals for the piecewise-constant intensities, in the estimation of the LEs we
impose a time grid.734 A. VAN DEN HOUT AND F. E. MATTHEWS
3.2 Using microsimulation
Let the time grid be given by u1 = 0,u2,...,uM with time between equal to 1 year. Given a simulated
parameter vector of the Markov model, a large number of trajectories through the states are simulated
conditional on baseline state. If there is a random-effect structure, then random effects are simulated for
each trajectory. If simulated states are denoted by their number, then individual survival in State 1 is
estimated by the number of 1s in the simulated trajectory plus half a year. The half-year correction is to
take into account that a transition to a next state can take place at any time in the year. Individual survival
in State 2 is estimated by the number of 2s. A ﬁner grid is of course possible, but the counting of the states
has to be adjusted to the grid.
Moreformally,thenestedsimulationprocedureaboveisasfollows.Letψ ψ ψ bethevectorwiththemodel
parameters. First, values ψ ψ ψb, b = 1,...,B, are simulated from the posterior of ψ ψ ψ. Second, conditional on
ψ ψ ψb, random effects τ τ τc
b, c = 1,...,C, are simulated. Next conditional on ψ ψ ψb and individual τ τ τc
b, a yearly
trajectory is simulated and individual survival (generically denoted by Lc
b) is calculated. Sample mean Lb
and variance Vb are stored and are used to estimate ﬁrst-order uncertainty Eψ ψ ψ[V[L|ψ ψ ψ]] and second-order
uncertainty Vψ ψ ψ[E[L|ψ ψ ψ]]. The former is the uncertainty caused by variability between individuals in the
population, the latter is what we are after: uncertainty caused by model parameter uncertainty. The sum of
these uncertainties is the total variance given by V[L] = Eψ ψ ψ[V[L|ψ ψ ψ]] + Vψ ψ ψ[E[L|ψ ψ ψ]] (cf. Spiegelhalter
and Best, 2003). In addition, we use the stored sample means to estimate E[L] = Eψ ψ ψ[E[L|ψ ψ ψ]].
O’Hagan and others (2007) discuss the choice of the number of simulations in the nested procedure,
that is, B for the ﬁrst level and C for the second level, and present a method to reduce the computational
burden in case one is only interested in the mean and the variance of L. In case the goal is the posterior
distribution of L, C has to be large. In the application, we used the method of O’Hagan and others (2007)
to check whether the chosen C was large enough.
4. RIGHT CENSORING
Often in longitudinal data there will be right censoring. If death during follow-up is always observed, right
censoring in our model means that if the state at the end of the study time is not observed, we still know
that the individual is alive.
To take right censoring into account, we extend the model in Section 2. First, states are denoted by X∗
and we code transition into the States 1, 2, 3, and the censored state by the vectors (1,0,0,0), (0,1,0,0),
(0,0,1,0), and (0,0,0,1), respectively. The vectors are denoted by X X X∗. The 3×3 matrix P P P is computed
as before. If the state at tM is neither death nor right censored, we assume that
X X X∗
j+1| x∗
tj,β β β12,β β β13,β β β23,τ τ τ ∼ Multinomial(π π π∗
j+1,1),
τ τ τ|       ∼ MVN(0 0 0,     ),
where
π π π∗
j+1 =
 
P P P(tj,tj+1)
 
x∗
tj,1
 
, P P P(tj,tj+1)
 
x∗
tj,2
 
, P P P(tj,tj+1)
 
x∗
tj,3
 
,0
 
for j = 1,...,M − 1. If the state at time tM is the death state or a censored state, we assume that
X X X∗
M| x∗
tM−1,β β β12,β β β13,β β β23,τ τ τ ∼ Multinomial(π π π∗
M,1),
where, in case of death, we deﬁne π π π∗
M = (π π πM,0) where π π πM is obtained by (2.6) after replacing the xtsb y
x∗
t s.Incaseofacensoredstate,wedeﬁneπ π π∗
M =
 
0,0, P P P(tM−1,tM)
 
x∗
tM−1,3
 
,1−P P P(tM−1,tM)
 
x∗
tM−1,3
  
.
By specifying the contribution to the likelihood as 1 − P P P(tM−1,tM)
 
x∗
tM−1,3
 
, that is, by the probabilityEstimating dementia-free life expectancy 735
of not dying within time interval (tM−1,tM], we follow the literature on multistate model (see, e.g. Kay,
1986). Note that the contribution can be seen as P(T > C) when T is deﬁned as time spent in the living
states and C as the censoring time.
5. APPLICATION
5.1 Data
In a region with 220000 inhabitants in Rogaland County, Norway, an attempt was made to recruit all
individuals with recognized idiopathic Parkinson’s disease. Parkinson’s disease was diagnosed in 245
individuals. To avoid inclusion of individuals with dementia with Lewy bodies, 18 individuals with clini-
cally signiﬁcant cognitive impairment were excluded from the study. During follow-up, 3 individuals died
before the ﬁrst assessment, 7 were rediagnosed as not having Parkinson’s disease, and 2 had schizophre-
nia, leaving n = 233 individuals eligible for the present study. The 233 individuals were followed from
baseline 1993 up to 2005. For those individuals who did not die before 2005, interviews took place in
1993, 1997 and 2001–2005. There are 3 individuals with a censored last state. For further details, see
Buter and others (2008).
In total, there were 897 observations (total number of interviews, censored states, and observed
deaths), which means that there were 897 − n = 664 observed intervals. The number of individuals
who died during study time is 187. Individuals with only one interview are also included. In the latter
case, observations consist of the initial state and a time of death or the initial state and the censored state
at the end of follow-up. The mean length of observed time intervals in years is 2.48 (median 1.48), and
the mean number of interviews is 3.03 (median 2).
Table 1 presents observed frequencies in each state at follow-up times. Because of the progressive
nature of dementia, a missing state can sometimes be derived from consecutively observed states. For
series of states 1?1, 2?2, and 2?3, where the question mark denotes a missing state, we know the missing
state. There are 10 individuals with intermediate missing states that cannot be derived in this way. These
missing states are noted in the table as the 6 + 5 + 4 + 4 + 3 = 22 censored states during follow-up.
Table 1. Observed and rounded expected frequencies in each state at follow-up times in the Rogaland
study, where (a + b) denotes a individuals previously in State 1 and b in State 2
State Time in years
Baseline 4 8 9 10 11 12
Observed
1 171 86 42 38 31 29 24
26 2 6 2 (43 + 19) 54 (25 + 29) 39 (2 + 37) 28 (2 + 26) 22 (1 + 21) 19 (5 + 14)
Dead 79 (36 + 43) 53 (20 + 33) 20 (3 + 17) 18 (5 + 13) 9 (2 + 7) 8 (0 + 8)
Censored 6 5 4433
Expected given Model 1
1 171 91 46 35 32 26 24
26 2 6 6 (42 + 22) 43 (21 + 22) 47 (5 + 42) 35 (5 + 30) 26 (4 + 22) 21 (4 + 17)
Dead 78 (38 + 40) 59 (19 + 40) 13 (1 + 12) 8 (1 + 9) 7 (1 + 6) 6 (1 + 5)
Expected given Model 2
1 171 87 49 37 33 27 25
26 2 6 4 (43 + 21) 44 (19 + 25) 46 (4 + 42) 35 (4 + 31) 25 (3 + 22) 21 (3 + 18)
Dead 83 (41 + 41) 55 (18 + 37) 13 (1 + 12) 9 (1 + 8) 7 (1 + 6) 5 (1 + 4)736 A. VAN DEN HOUT AND F. E. MATTHEWS
Table 2. Frequencies of observed transitions between the states in the Rogaland study
To state Death Censored
1 2
From state 1 250 78 66 3
2 0 146 121 0
Missing intermediate states is not a problem for the estimation of the model but might bias results if
the missingness is substantial. Our piecewise-constant model assumes that intensities are not changing
between the interviews but might change from interview to interview. Missing several interviews affects
the piecewise-constant approximation to the continuous time dependency of the intensities. Since there
are only 10 persons with missing intermediate interviews and only 2 of them with more than 1 consecutive
interview missing, we assume that the bias is negligible.
Frequencies of observed transitions between the states are given in Table 2. Note that there are no
transitions from State 2 back to State 1. Three covariates will be used in the model: time-dependent age
in years minus 77, sex as a dummy (0 ≡ men), and duration as the number of years the individual had
Parkinson’s disease before 1993 centered by subtracting 9 years. Before centering, minimum, mean, and
maximum for age in years during follow-up are 36, 77.42, and 101, respectively. Minimum, mean, and
maximum duration of Parkinson’s disease in years are 1, 8.89, and 34, respectively. The time interval  
that is used to approximate exact transition times into the death state is ﬁxed to be   = 0.001 years. This
value was chosen because it is small, and there is no individual in the data who dies within 0.001 years of
their last interview.
5.2 Models
Using t as the number of years since baseline, we specify 2 models. The models are the results of a model
comparison that can be found in Section A of the supplementary material available at Biostatistics online.
Fixed-effect Model 1 encompasses a model for the baseline state and one for the intensities and is given
for individual i by
logit(θi) = α0 + αaAgei(0) + αsSexi + αdDurationi,
log[qi
rs(t)] = β0.rs + βa.rsAgei(t) + βs.rsSexi + βd.rsDurationi,
βs.13 = βd.13 = βd.23 = αs = 0.
Model 2 has the same model for the baseline and the same restrictions for the ﬁxed effects. The model for
the intensities, however, is extended with random effects and is given by
log[qi
rs(t)] = β0.rs + βa.rsAgei(t) + βs.rsSexi + βd.rsDurationi + τi
rs(t),
τi
rs(t) = γ i
0.rs + γ i
aAgei(t),
γ γ γ i = (γ i
0.12,γi
0.13,γi
0.23,γi
a)  ∼ MVN(0 0 0,     ).
Model 2 for the intensities is a slightly extended version of model (2.1). We include the random slope γ i
a
to allow τi
rs(t) to change over time.
For the ﬁxed-effect regression coefﬁcients in Models 1 and 2, we speciﬁed vague univariate normal
distributionswithmeanzeroandvarianceequalto1000.ForModel2,apriorisneededfor4×4covariance
matrix      . Here we followed common practice and used a Wishart distribution to specify the prior of theEstimating dementia-free life expectancy 737
precision matrix T T T =      −1, that is, T T T ∼ W(R R R−1,4), where R R R i sa4× 4 matrix. Since E[T T T] = 4R R R−1,i t
follows that 4−1R R R can be seen as a prior guess at the order of magnitude of      .
Given a model, MCMC consisted of 2 chains with different starting values for α α α, β β β12,β β β13, and β β β23.
For both chains, the ﬁrst 50000 iterations were ignored (burn-in) and the additional 50000 iterations were
thinned and used to compute the posterior means, the 95% credible intervals, and the deviance informa-
tion criterion (DIC, Spiegelhalter and others, 2002). For the models in this paper, the MCMC took about
2 h to run on a 2.59-GHz PC with dual core AMD microprocessor. Convergence of the chain was checked
visually by plotting the chains, the autocorrelation, and the Gelman–Rubin convergence statistic, as modi-
ﬁed by Brooks and Gelman (1998). Numerically, convergence was assessed by checking the Monte Carlo
error. All these functions can be called within OpenBUGS. We used the DIC to compare models. The DIC
comparison is based on trade-off between the ﬁt of the data to the model and the complexity of the model.
Models with smaller DIC are better supported by the data.
Both Models 1 and 2 have DIC = 4142. It makes sense in this case to choose Model 1 as it is the
most parsimonious. However, we think that Model 2 is interesting as it includes random effects to capture
possible heterogeneity not captured by the covariates and it allows random effects to change over time by
regressing the effects on time-dependent age. To estimate LEs, we have to extrapolate the model beyond
the follow-up of the survey. Assuming no heterogeneity beyond the covariates and no further change over
time beyond the ﬁxed effect of age might be too restrictive.
A sensitivity analysis with regard to the speciﬁcation of priors was conducted. For the ﬁxed effects,
alternative univariate normal distributions were investigated with mean zero and variance equal to either
100 or 10000. For Model 2, alternative priors for the precision matrix T T T were considered. Denote the
diagonal entries of R R R for the random intercepts r1 and the diagonal entries for the random slopes r2.
The DICs varied slightly for speciﬁcations (r1,r2) = (1,0.001), (r1,r2) = (2,0.01), and (r1,r2) =
(0.25,0.001), but we do not consider the variation to be signiﬁcant. (For details, see Section B of the
supplementary material available at Biostatistics online.)
5.3 Inference
Table 3 presents posterior means for the parameters in Models 1 and 2. For Model 2, we provide posterior
meansofσ0.12 =      
1/2
11 ,σ0.13 =      
1/2
22 ,σ0.23 =      
1/2
33 ,andσa =      
1/2
44 .Therearedifferencesintheposterior
means of the covariate effects. Note that for Model 2, the means for the covariate effects are all larger than
for Model 1. These differences and the posterior means of standard deviations of σ0.12,σ 0.12,σ 0.23, and
σa show that adding the random effects lead to a different description of the data.
Both models show that for individuals with Parkinson’s disease but without dementia, sex and the
duration of the disease at baseline do not have an effect on the intensities for transitions to the death
state. Further restriction, βd.23 = 0 indicates that for individuals with Parkinson’s disease and dementia,
the history of the disease at baseline does not have an effect on the transition to the death state. The
unrestricted regression coefﬁcients show that all covariates are important for the onset of dementia and
that given Parkinson’s disease men are more likely to become demented than women of the same age and
with the same history of the disease at baseline. Posterior means for the logistic regression model for the
baseline state probability θ = P(X0 = 2|z z z(0)) show that with increasing age and more years of duration,
it is more likely that the patient is demented. This concurs with our expectations.
The computation of the LEs was done using the posterior of the model parameters derived from
MCMC after the burn-in. The time between h in the time grid for the LEs was 1 year. Table 4 presents
the results. For Model 1 without random effects, we used both microsimulation and the trapezoidal rule in
order to compare performance. For Model 2, we used microsimulation. To approximate LE given by (3.1),
we impose a time that represents inﬁnity conditional on speciﬁed age at baseline. This time is the time738 A. VAN DEN HOUT AND F. E. MATTHEWS
Table 3. Posterior means and DICs for Models 1 and 2 each including a Markov model and a logistic
regression model for the baseline; 95% credible intervals in parentheses
Model 1 Model 2
Markov model
Intercepts β0.12 −1.496 (−1.795,−1.221) −1.394 (−1.772,−1.015)
β0.13 −4.013 (−5.127,−3.271) −4.342 (−5.716,−3.420)
β0.23 −1.286 (−1.533,−1.053) −1.288 (−1.574,−1.009)
Age βa.12 0.086 (0.057,0.115) 0.105 (0.066,0.152)
βa.13 0.050 (−0.028,0.147) 0.057 (−0.035,0.167)
βa.23 0.027 (0.005,0.054) 0.043 (0.010,0.079)
Sex βs.12 −0.571 (−0.970,−0.174) −0.590 (−1.098,−0.091)
βs.13 0† 0†
βs.23 −0.361 (−0.682,−0.038) −0.427 (−0.809,−0.059)
Duration βd.12 0.069 (0.027, 0.111) 0.080 (0.029, 0.136)
βd.13 0† 0†
βd.23 0† 0†
Random effect σ0.12 0.650 (0.350, 1.111)
σ0.13 0.748 (0.349, 1.583)
σ0.23 0.436 (0.280, 0.653)
σa 0.047 (0.030, 0.071)
Logistic regression model
Intercept α0 −0.914 (−1.255,−0.584) −0.912 (−1.261,−0.581)
Age αa 0.166 (0.112,0.224) 0.165 (0.112,0.225)
Sex αs 0† 0†
Duration αd 0.047 (−0.009,0.104) 0.047 (−0.008,0.103)
† Restricted to zero.
to assumed maximum age minus age at baseline. For maximum age, we choose 110 years old, which—
for Parkinson’s disease patients—seems reasonable. Microsimulation is computationally intensive. For
B = C = 1000,thesimulationtooktwicethetimetakentoestimatethemodelviaMCMC.Theestimation
seems to be robust regarding the speciﬁcation of the time between in the time grid. For h equal to 1/2 year,
the results (not shown) are very similar.
Using the 1-way analysis of variance technique proposed by O’Hagan and others (2007), we checked
results by comparing estimated standard errors. For C = 1000, there is indeed some consistent overesti-
mation, but the bias is negligible for practical purposes. (For details, see Section C of the supplementary
material available at Biostatistics online.)
For Model 1, the posterior densities of the LEs for men aged 60 years at baseline with 8 years of
Parkinson’s disease at baseline are given in Figure 1. The dashed lines are the expectancies computed
using the trapezoidal rule, and the solid lines are the expectancies computed using microsimulation. The
results for the trapezoidal rule are a bit smoother. Overall, however, differences are minimal.
For Model 2, credible intervals are wider. This is to be expected as there will be more variation due
to the random effects. Posterior means for LEs for Model 2 are higher than the means for Model 1,
especially for e11 and e1. This is not due to skewed distributions for Model 2. Median LEs (not shown)
are very similar to the means reported in Table 4. Note that given a speciﬁc age at baseline, zero is the
lower bound for the simulated LE, but there is no upper bound other than the assumed maximum age. The
higher LEs for Model 2 are caused by simulated random effects that reﬂect more healthy individuals withEstimating dementia-free life expectancy 739
Table 4. Posterior means for LEs for men with 8 years of Parkinson’s disease at baseline. Estimation for
Models 1 and 2 with 95% credible intervals in parentheses
Model 1 Model 2
Trapezoidal rule Microsimulation Microsimulation
(B = 1000) (B = C = 1000) (B = C = 1000)
Age 60 years
e11 8.7 (7.1, 10.4) 8.8 (7.0, 10.5) 9.4 (7.5, 11.5)
e12 3.5 (2.6, 4.5) 3.5 (2.6, 4.6) 3.7 (2.7, 5.0)
e22 5.0 (3.1, 7.0) 5.0 (3.1, 7.2) 6.3 (4.0, 8.7)
e1 8.5 (6.9, 10.1) 8.5 (6.8, 10.3) 9.2 (7.3, 11.3)
e2 3.6 (2.7, 4.6) 3.6 (2.6, 4.6) 3.8 (2.7, 5.0)
etot 12.0 (10.3, 13.8) 12.1 (10.2, 14.0) 13.0 (10.9, 15.1)
Age 70 years
e11 5.0 (4.1, 5.9) 5.0 (4.1, 6.0) 5.3 (4.2, 6.6)
e12 3.1 (2.5, 3.8) 3.1 (2.5, 3.9) 3.3 (2.5, 4.2)
e22 3.9 (3.0, 4.8) 3.9 (3.0, 4.9) 4.3 (3.2, 5.6)
e1 4.4 (3.6, 5.3) 4.4 (3.7, 5.4) 4.7 (3.7, 5.9)
e2 3.2 (2.6, 3.9) 3.2 (2.5, 4.0) 3.4 (2.6, 4.4)
etot 7.6 (6.7, 8.6) 7.7 (6.7, 8.7) 8.1 (6.9, 9.4)
Fig. 1. For Model 1, posterior distributions of the LEs for men aged 60 years at baseline with 8 years of Parkinson’s
disease at baseline (solid lines for microsimulation; dashed lines for trapezoidal rule).740 A. VAN DEN HOUT AND F. E. MATTHEWS
relatively long lives. This trend may reﬂect the data where there is less information for the more healthy
individuals who stay in State 1 during the whole follow-up.
Even though the 2 models yield different estimates, the differences are within bounds. Looking at
the results for Models 1 and 2 for the LEs, it is interesting to note that the years spent with dementia
irrespective of baseline state (e2) do not differ much for the ages 60 and 70. Given that the extrapolation
is largest for those aged 60 years, it is understandable that the 95% credible intervals are wider for those
aged 60 years than for those aged 70 years.
5.4 Validation
Given the regular observation times in the Rogaland study, we can investigate some aspects of goodness of
ﬁtbycomparingobservedfrequenciesineachstatewithexpectedfrequencies.Theapproachisinspiredby
the model assessment in the R package for multistate models msm (Jackson and others, 2003) but differs
from msm in that it works with the observed covariate values at baseline. In principle, the setup makes it
possible to use the Bayesian χ2 test for goodness-of-ﬁt as introduced by Johnson (2004). However, this
χ2 test relies on asymptotic properties that are not met in our situation. (For details see Section D of the
supplementary material available at Biostatistics online.)
Observation times other than death take place at years t0,t1,...,t6 = 0,4,8,9,10,12. Let n denote
the number of individuals in the data and let Xi
t denote the state of individual i at time t. For State
s ∈{ 1,2,censored}, deﬁne observed frequencies O[s,tj] =
 n
i=1 1 l{Xi
tj = s}, for j = 2,...,6. Given
the known death times, we deﬁne O[dead,tj] =
 n
i=1 1 l{∃t∗[tj−1 < t∗ < tj ∧ Xi
t∗ = dead]}, for j =
2,...,6. These frequencies are presented in Table 1. The table also shows the observed frequencies split
according to the previously observed state. For example, 4 years after baseline, from the 62 individuals
who are observed in State 2, 43 were observed in State 1 at baseline and 19 were observed in State 2 at
baseline.
Observed frequencies can be compared with expected frequencies by deﬁning table E[t] =
 n
i=1
P P Pi(t,0), where P P Pi(t,0) is the matrix with the transition probabilities for individual i derived from a sim-
ulated model parameter vector (for Model 2, this includes the random effects). The individual transition
matrices are approximated using the grid approach in (3.3), where the grid is given by t0,t1,...,t6.I n
this approximation, the covariate values of individual i at baseline are used and the change of age at the
grid points is taken into account.
For a visual inspection of goodness of ﬁt, 1000 simulated values of the parameter vectors are used to
computed 1000 times E[t]. For Models 1 and 2, the mean of the 1000 simulated tables is presented in
Table 1 as the expected frequencies. In general, observed and expected frequencies are similar for both
models. There is a deviation for State 2 in the later years in the sense that the number of individuals in
State 2 is overestimated and the number of deaths underestimated. Although this is not a proper statistical
test, Table 1 shows that Models 1 and 2 ﬁt the data reasonably well.
6. DISCUSSION
LEs in health and ill health can be of importance for the planning of future health care. Survival is not
only about total LE but also about whether or not remaining life time will be spent in good health. For
longitudinal data, we have shown how transitions between health, ill health, and death can be modeled
using the Bayesian framework. In addition, we have shown how to estimate the posterior densities of
LEs in health and ill health. In many longitudinal studies, transition intensities will change over time and
one way of taking this into account is to include age as a time-dependent covariate for the intensities.
The approach is illustrated using a 3-state model without recovery for Parkinson’s patients where
dementia represents ill health. BUGS was used for estimation with MCMC. The model in the paperEstimating dementia-free life expectancy 741
can be extended to more complex models, for instance models with recovery from the ill health state
or model with more states. When there is a closed-form expression for the matrix with the transition
probabilities given the transition intensities, the standard functions in BUGS can be used to estimate the
model. Another possibility is to disentangle the effect of baseline age and the effect of time by using
qrs(t) = exp[β0.rs + βt.rst + βa.rsAge(0) +···], where Age(0) is age at the start of the study.
Interval censoring is an important feature of the data that we analyzed. If exact transition times had
been available for transitions out of State 1, standard survival models might have been applied to estimate
LE in State 1. The problem for an observed series of states such as 1113 is that we do not know whether the
latent trajectory was via State 2 or directly from State 1 to State 3. We could right censor the series midway
the last time interval as an approximation, but this leads to 100% censoring. For LE in State 2, standard
survival models be sufﬁcient, but it will only address part of our research question. Applying a multistate
model seems to be best option as it formulates an overall model and makes it possible to borrow strength
across the transitions, for example, via shared random effects such as the random slopes in the application.
The ﬁrst-order Markov assumption that is often used in applications of multistate models is not always
realistic. The model for the Parkinson’s disease study uses the Markov assumption, and the informal
assessment of goodness of ﬁt shows that the model ﬁts the data well. The use of age as a time-dependent
covariate is crucial here. For example, time spent in the dementia state might have an effect on the risk of
moving to the death state, but part of this is covered by the effect of changing age.
We have illustrated the use of microsimulation in the estimation of LEs when the regression model
for the intensities includes random effects. Direct numerical approximation of the complex multidimen-
sional integral that takes into account random effects and time-dependent age may often not be feasible.
Microsimulation is an alternative that is intuitive and easy to implement. We think that microsimulation
has potential for more complex multistate models. To estimate LEs, the multistate model is extrapolated
beyond the follow-up of the study and this asks for special methods in case covariates are not determin-
istic. For example, given a 3-state illness–death model with recovery, it is possible to add the covariate
“previously observed in State 2”. This covariate is not deterministic but can be used in a microsimulation
where individual trajectories are simulated and the next state is simulated conditional on the history of
previously simulated states.
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